A Small Molecule Inhibits and Misdirects Assembly of Hepatitis B Virus Capsids

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2002 Apr 23

PMID 11967301

Citations 60

Authors

Adam Zlotnick

Pablo Ceres

Sushmita Singh

Jennifer M Johnson

Affiliations

Soon will be listed here.

Abstract

Hepatitis B virus (HBV) capsids play an important role in viral nucleic acid metabolism and other elements of the virus life cycle. Misdirection of capsid assembly (leading to formation of aberrant particles) may be a powerful approach to interfere with virus production. HBV capsids can be assembled in vitro from the dimeric capsid protein. We show that a small molecule, bis-ANS, binds to capsid protein, inhibiting assembly of normal capsids and promoting assembly of noncapsid polymers. Using equilibrium dialysis to investigate binding of bis-ANS to free capsid protein, we found that only one bis-ANS molecule binds per capsid protein dimer, with an association energy of -28.0 +/- 2.0 kJ/mol (-6.7 +/- 0.5 kcal/mol). Bis-ANS inhibited in vitro capsid assembly induced by ionic strength as observed by light scattering and size exclusion chromatography. The binding energy of bis-ANS for capsid protein calculated from assembly inhibition data was -24.5 +/- 0.9 kJ/mol (-5.9 +/- 0.2 kcal/mol), essentially the same binding energy observed in studies of unassembled protein. These data indicate that capsid protein bound to bis-ANS did not participate in assembly; this mechanism of assembly inhibition is analogous to competitive or noncompetitive inhibition of enzymes. While assembly of normal capsids is inhibited, our data suggest that bis-ANS leads to formation of noncapsid polymers. Evidence of aberrant polymers was identified by light scattering and electron microscopy. We propose that bis-ANS acts as a molecular "wedge" that interferes with normal capsid protein geometry and capsid formation; such wedges may represent a new class of antiviral agent.

Citing Articles

Discovery of bimodal hepatitis B virus ribonuclease H and capsid assembly inhibitors.

Bradley D, Valkner C, Li Q, Gasonoo M, Meyers M, Prifti G PLoS Pathog. 2025; 21(2):e1012920.

PMID: 39928681 PMC: 11828405. DOI: 10.1371/journal.ppat.1012920.

Antiviral Agents: Structural Basis of Action and Rational Design.

Menendez-Arias L, Gago F Subcell Biochem. 2024; 105:745-784.

PMID: 39738962 DOI: 10.1007/978-3-031-65187-8_20.

Guanidine Hydrochloride-Induced Hepatitis B Virus Capsid Disassembly Hysteresis.

Khaykelson D, Asor R, Zhao Z, Schlicksup C, Zlotnick A, Raviv U Biochemistry. 2024; 63(12):1543-1552.

PMID: 38787909 PMC: 11191408. DOI: 10.1021/acs.biochem.4c00077.

Effect of ionic strength on the assembly of simian vacuolating virus capsid protein around poly(styrene sulfonate).

Asor R, Singaram S, Levi-Kalisman Y, Hagan M, Raviv U Eur Phys J E Soft Matter. 2023; 46(11):107.

PMID: 37917241 PMC: 11827716. DOI: 10.1140/epje/s10189-023-00363-x.

Current Progress in the Development of Hepatitis B Virus Capsid Assembly Modulators: Chemical Structure, Mode-of-Action and Efficacy.

Kim H, Ko C, Lee J, Kim M Molecules. 2021; 26(24).

PMID: 34946502 PMC: 8705634. DOI: 10.3390/molecules26247420.

References

Stannard L, Hodgkiss M . Morphological irregularities in Dane particle cores. J Gen Virol. 1979; 45(2):509-14. DOI: 10.1099/0022-1317-45-2-509. View

Takashi R, Tonomura Y, Morales M . 4,4'-Bis (1-anilinonaphthalene 8-sulfonate) (bis-ANS): a new probe of the active site of myosin. Proc Natl Acad Sci U S A. 1977; 74(6):2334-8. PMC: 432165. DOI: 10.1073/pnas.74.6.2334. View

Musci G, Berliner L . Probing different conformational states of bovine alpha-lactalbumin: fluorescence studies with 4,4'-bis[1-(phenylamino)-8-naphthalenesulfonate]. Biochemistry. 1985; 24(15):3852-6. DOI: 10.1021/bi00336a006. View

Salfeld J, Pfaff E, Noah M, Schaller H . Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J Virol. 1989; 63(2):798-808. PMC: 247753. DOI: 10.1128/JVI.63.2.798-808.1989. View

Birnbaum F, Nassal M . Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J Virol. 1990; 64(7):3319-30. PMC: 249568. DOI: 10.1128/JVI.64.7.3319-3330.1990. View

Bartenschlager R, Schaller H . The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J Virol. 1990; 64(11):5324-32. PMC: 248581. DOI: 10.1128/JVI.64.11.5324-5332.1990. View

Secnik J, Wang Q, Chang C, Jentoft J . Interactions at the nucleic acid binding site of the avian retroviral nucleocapsid protein: studies utilizing the fluorescent probe 4,4'-bis(phenylamino)(1,1'-binaphthalene)-5,5'-disulfonic acid. Biochemistry. 1990; 29(34):7991-7. DOI: 10.1021/bi00486a030. View

Saha R, Banik U, Bandopadhyay S, Mandal N, Bhattacharyya B, Roy S . An operator-induced conformational change in the C-terminal domain of the lambda repressor. J Biol Chem. 1992; 267(9):5862-7. View

Zhou S, Standring D . Hepatitis B virus capsid particles are assembled from core-protein dimer precursors. Proc Natl Acad Sci U S A. 1992; 89(21):10046-50. PMC: 50274. DOI: 10.1073/pnas.89.21.10046. View

10.

Seifer M, Zhou S, Standring D . A micromolar pool of antigenically distinct precursors is required to initiate cooperative assembly of hepatitis B virus capsids in Xenopus oocytes. J Virol. 1993; 67(1):249-57. PMC: 237358. DOI: 10.1128/JVI.67.1.249-257.1993. View

11.

Prevelige Jr P, Thomas D, King J . Nucleation and growth phases in the polymerization of coat and scaffolding subunits into icosahedral procapsid shells. Biophys J. 1993; 64(3):824-35. PMC: 1262396. DOI: 10.1016/S0006-3495(93)81443-7. View

12.

Seifer M, Standring D . Stability governs the apparent expression of "particulate" hepatitis B e antigen by mutant hepatitis B virus core particles. Virology. 1993; 196(1):70-8. DOI: 10.1006/viro.1993.1455. View

13.

Teschke C, King J, Prevelige Jr P . Inhibition of viral capsid assembly by 1,1'-bi(4-anilinonaphthalene-5-sulfonic acid). Biochemistry. 1993; 32(40):10658-65. DOI: 10.1021/bi00091a016. View

14.

Crowther R, Kiselev N, Bottcher B, Berriman J, Borisova G, Ose V . Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell. 1994; 77(6):943-50. DOI: 10.1016/0092-8674(94)90142-2. View

15.

Shi L, Palleros D, Fink A . Protein conformational changes induced by 1,1'-bis(4-anilino-5-naphthalenesulfonic acid): preferential binding to the molten globule of DnaK. Biochemistry. 1994; 33(24):7536-46. DOI: 10.1021/bi00190a006. View

16.

Zlotnick A . To build a virus capsid. An equilibrium model of the self assembly of polyhedral protein complexes. J Mol Biol. 1994; 241(1):59-67. DOI: 10.1006/jmbi.1994.1473. View

17.

Scaglioni P, Melegari M, Wands J . Characterization of hepatitis B virus core mutants that inhibit viral replication. Virology. 1994; 205(1):112-20. DOI: 10.1006/viro.1994.1625. View

18.

Wingfield P, Stahl S, Williams R, Steven A . Hepatitis core antigen produced in Escherichia coli: subunit composition, conformational analysis, and in vitro capsid assembly. Biochemistry. 1995; 34(15):4919-32. DOI: 10.1021/bi00015a003. View

19.

Kenney J, von Bonsdorff C, Nassal M, Fuller S . Evolutionary conservation in the hepatitis B virus core structure: comparison of human and duck cores. Structure. 1995; 3(10):1009-19. DOI: 10.1016/s0969-2126(01)00237-4. View

20.

Zlotnick A, Cheng N, Conway J, Booy F, Steven A, Stahl S . Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein. Biochemistry. 1996; 35(23):7412-21. DOI: 10.1021/bi9604800. View